Three states filed a lengthy complaint Thursday in Amarillo federal court reviving the dormant lawsuit challenging looser restrictions on the use of an abortion drug.
A federal judge in Texas ruled that three states can challenge the current rules of accessibility for abortion pills.
President-elect Trump campaigned on leaving abortion decisions to the states, but that could prove a tough promise to keep as he returns to the Oval Office. Anti-abortion groups want Trump
The states of Idaho, Kansas and Missouri can now move ahead with their efforts in U.S. District Court in Amarillo, Texas, where a nominee of former President Donald Trump is the only judge.
Instead of dismissing the case, Judge Matthew Kacsmaryk said three states with no connection to Texas can sue the FDA to try to reimpose restrictions on mifepristone.
Three Republican-led states can go forward with their lawsuit that seeks to restrict the availability of the abortion pill mifepristone, a judge ruled on Thursday. U.S. District Judge Matthew Kacsmaryk in Amarillo,
The Trump-appointed federal judge who unilaterally ordered the FDA to revoke approval of an abortion drug allowed Idaho, Kansas and Missouri to move forward in another lawsuit over mifepristone.
Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit the FDA from allowing online prescriptions.
The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of the abortion pill mifepristone
Michael Karlis is a Staff Writer at the San Antonio Current. He is a graduate of American University in Washington, D.C., whose work has been featured in Salon, Alternet, Creative Loafing Tampa Bay, Orlando Weekly, NewsBreak, 420 Magazine and Mexico Travel Today. He reports primarily on breaking news, politics...
Idaho, Kansas and Missouri want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used only in the first seven weeks of
Three states will get to proceed with their challenge to the use of an abortion drug - after a ruling by a federal judge in Texas. Idaho, Kansas and Missouri want the FDA to block the drug mifepristone.